CG Oncology Inc. Common stock
CGONUnited States
19 filed reports · 228 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
19 reports · Mar 2024 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 109 commentary passages.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 15 | 1,003 | Mar 2024 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 4 | 745 | Dec 2024 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 6, 2026 | 2 | Open |
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 6, 2026 | 225 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 8, 2026 | 1 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 8, 2026 | 142 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 27, 2026 | 2 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 27, 2026 | 558 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 14, 2025 | 160 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 14, 2025 | 1 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 8, 2025 | 1 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 8, 2025 | 98 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 13, 2025 | 1 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 13, 2025 | 97 | Open |
Financial data
228 concepts · 1,748 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial227 concepts · 1,726 facts · Dec 2022 to Aug 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value17 · Mar 2023 to Jun 2026
- Allocated share based compensation expense17 · Mar 2023 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents17 · Mar 2023 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect17 · Mar 2023 to Jun 2026
- Depreciation depletion and amortization17 · Mar 2023 to Jun 2026
- General and administrative expense (US GAAP)17 · Mar 2023 to Jun 2026
- Increase decrease in accounts payable17 · Mar 2023 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets17 · Mar 2023 to Jun 2026
- Investment income interest17 · Mar 2023 to Jun 2026
- Lease cost17 · Mar 2023 to Jun 2026
- Net cash provided by used in financing activities17 · Mar 2023 to Jun 2026
- Net cash provided by used in investing activities17 · Mar 2023 to Jun 2026
- Net cash provided by used in operating activities17 · Mar 2023 to Jun 2026
- Net income loss17 · Mar 2023 to Jun 2026
- Non-cash lease expense17 · Mar 2023 to Jun 2026
- Nonoperating income expense17 · Mar 2023 to Jun 2026
- Operating income loss17 · Mar 2023 to Jun 2026
- Operating lease cost17 · Mar 2023 to Jun 2026
- Operating lease payments17 · Mar 2023 to Jun 2026
- Operating lease weighted average discount rate percent17 · Mar 2023 to Jun 2026
- Other nonoperating income expense17 · Mar 2023 to Jun 2026
- Profit loss17 · Mar 2023 to Jun 2026
- Research and development expense17 · Mar 2023 to Jun 2026
- Revenue17 · Mar 2023 to Jun 2026
Product1 concepts · 22 facts · Dec 2023 to Jun 2026
- Revenue22 · Dec 2023 to Jun 2026
Segments
22 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service2 members · 22 facts
- Commercial And Development Revenue11 · Dec 2023 to Jun 2026
- License And Collaboration Revenue11 · Dec 2023 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary67 claims from 8 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary109 claims from 7 reports · Sep 2024 to Jun 2026
- Risk-factor changes30 claims from 1 reports · Dec 2025
- Risk factors158 risks from 2 annual reports · 2024 to 2025
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.